Business Context and Reporting Period
Company: Steakholder Foods Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of August 2026
Key Event: Completion of a private placement offering (the "Offering") on August 3, 2026, following a securities purchase agreement entered into on July 31, 2026.
Key Financial Metrics
Capital Raised: Approximately $3.5 million in gross proceeds (assuming full exercise of Pre-Funded Warrants).
Use of Proceeds: Funding research and development, business growth, working capital, and general corporate purposes.
Transaction Costs:
- Placement agent fee: 7.5% of gross proceeds.
- Non-accountable expense allowance: $25,000.
- Legal fees and expenses: $50,000.
Financial Performance: The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on the capital raise transaction.
Material Changes
The primary material change is the issuance of new securities to an accredited investor, which will increase the company's authorized share count and outstanding share equivalents upon exercise. The Offering includes:
- Pre-Funded Warrants: 1,750,000 units (each representing 12,000 ordinary shares) at $1.99 per unit. Immediately exercisable at $0.01 per ADS.
- Series E Warrants: 1,750,000 units to purchase ADSs at $2.00 per ADS. Exercisable after shareholder approval of authorized share increase; expire 18 months after the later of the Effective Date or Authorized Share Increase Date.
- Series F Warrants: 1,750,000 units to purchase ADSs at $2.00 per ADS. Exercisable after shareholder approval; expire 5 years after the later of the Effective Date or Authorized Share Increase Date.
- Placement Agent Warrants: 122,500 units (7.0% of Pre-Funded Warrants) issued to H.C. Wainwright & Co., LLC at an exercise price of $2.50 per ADS.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize net proceeds to accelerate R&D and business growth.
Restrictions:
- Lock-up: The Company is restricted from issuing new ADSs or filing registration statements for 60 days following the Effective Date (subject to exceptions).
- Variable Rate Transactions: Prohibited for one year following the Effective Date.
- Beneficial Ownership Limit: Warrant holders cannot exercise if it would result in beneficial ownership exceeding 4.99% of outstanding ordinary shares.
Risks and Contingencies:
- Registration Rights: The Company must file a resale registration statement within 15 days and use best efforts to have it declared effective within 45 days (or 75 days if reviewed by the SEC).
- Cashless Exercise: If no effective registration statement exists for resale, Ordinary Warrants may only be exercised on a cashless basis.
- Shareholder Approval: Exercise of Series E and F warrants is contingent upon shareholder approval of an increase in authorized ordinary shares.
Investor Verification Checklist
- Verify the status of the shareholder vote required to increase authorized ordinary shares, which is a condition for exercising Series E and F warrants.
- Confirm the filing and effectiveness date of the Resale Registration Statement (Form S-1 or similar) to determine if cashless exercise restrictions apply.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific anti-dilution provisions and customary exceptions to the lock-up period.
- Assess the impact of the 7.5% placement fee and additional warrant issuance on existing shareholder dilution.
- Monitor the company's cash burn rate relative to the $3.5 million gross proceeds to evaluate runway for R&D and operations.